2-Aminomethylpyrinidine Hydrochloride CAS 372118-67-7 Assay >99.0% (HPLC) Factory Hot Sale

Short Description:

Chemical Name: 2-Aminomethylpyrinidine Hydrochloride 

CAS: 372118-67-7

Assay: >99.0% (HPLC)

Appearance: Light Yellow to Off-White Powder

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Manufacturer Supply, High Purity, Commercial Production 
Chemical Name: 2-Aminomethylpyrinidine Hydrochloride 
CAS: 372118-67-7

Chemical Properties:

Chemical Name 2-Aminomethylpyrinidine Hydrochloride
Synonyms 2-Aminomethylpyrimidine HCl; 2-Pyrimidinemethanamine Hydrochloride; Pyrimidin-2-Ylmethanamine Hydrochloride
CAS Number 372118-67-7
CAT Number RF-PI851
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C5H8ClN3
Molecular Weight 145.59
Boiling Point 218.7℃ at 760 mmHg
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Light Yellow to Off-White Powder
Identification NMR/LC-MS/HPLC
Assay / Analysis Method >99.0% (HPLC) 
Loss on Drying ≤0.50%
Residue on Ignition ≤0.30%
Individual Impurity ≤0.50%
Total Impurities ≤1.0%
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

1

FAQ:

Application:

2-Aminomethylpyrinidine Hydrochloride (CAS: 372118-67-7) is a synthetic intermediate useful for pharmaceutical synthesis. 2-Aminomethylpyrinidine Hydrochloride is a reagent and an intermediate that is used for pharmaceutical synthesis such as spirocyclic acylguanidines as beta-secretase inhibitors for treatment of neurodegenerative disorders. 2-Aminomethylpyrinidine Hydrochloride can be used as a intermediate in the synthesise of Avanafil (CAS: 330784-47-9). Avanafil (Zepeed) was approved by the Korean Health Ministry for the treatment of erectile dysfunction (ED) in August 2011. 

  • Write your message here and send it to us